HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Westerlund, J. Articles by Bergsten, P. Search for Related Content PubMed PubMed Citation Articles by Westerlund, J. Articles by Bergsten, P. Social Bookmarking                What's this?

Glucose-Dependent Promotion of Insulin Release From Mouse Pancreatic Islets by the Insulin-Mimetic Compound L-783,281

¹ Department of Medical Cell Biology, Uppsala University, Sweden
² Department of Pathology and Laboratory Medicine, the Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

	ABSTRACT

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
An insulin-mimetic compound (L-783,281) was used in an attempt to determine the role of the ß-cell insulin receptor (IR) on insulin release. Islets were isolated from C57Bl/6j mice and cultured for 1 to 4 days. Insulin release from individual islets perifused in the presence of 3 mmol/l glucose was 10.5 ± 1.4 pg/min. Addition of 10 µmol/l L-783,281 had no effect on the rate of insulin secretion. When L-783,281 was added to perifusion medium containing 11 mmol/l glucose, the insulin-mimetic compound significantly increased insulin release. Insulin release from the isolated islet is pulsatile. In the presence of 3 mmol/l glucose, addition of L-783,281 significantly decreased the frequency of the oscillations from 0.35 ± 0.03 to 0.22 ± 0.04 oscillations/min. Addition of L-783,281 to perifusion medium containing 11 mmol/l glucose had no effect on the frequency of the insulin pulses (0.30 ± 0.05 oscillations/min). These results indicate that activation of the ß-cell IR by L-783,281 augments insulin release in the presence of a stimulatory glucose concentration. At nonstimulatory glucose concentrations, activation of the ß-cell IR may affect mechanisms related to the frequency of the insulin pulses.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

	RESEARCH DESIGN AND METHODS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
Materials.
Reagents of analytical grade and deionized water were used. Collagenase, HEPES, and bovine serum albumin (fraction V) were obtained from Boehringer Mannheim GmbH (Mannheim, Germany). Tetramethylbenzidine and insulin-peroxidase came from Sigma (St. Louis, MO). The rat insulin standard was from Novo Nordisk (Bagsvaerd, Denmark). Immunoglobulin G–certified microtiter plates were purchased from Nunc (Roskilde, Denmark). The mouse insulin antibodies were raised in guinea pigs in our laboratory. The insulin analog L-783,281 was obtained from Merck.

Preparation and culture of islets.
Pancreatic islets were collagenase isolated from C57Bl/6j mice (B&K, Sollentuna, Sweden). The islets were cultured for 1 to 4 days in 11 mmol/l glucose in RPMI culture medium supplemented with 10% fetal calf serum, 100 IU/ml penicillin, 100 µg/ml strepotomycin, and 30 µg/ml gentamicin. The experiments were approved by the local animal ethics committee.

Perifusion of islets.
The kinetics of insulin release were studied essentially as described previously (12). A single islet was placed in a 10-µl chamber (thermostat at 37°C) and perifused at a constant flow rate with medium containing 3 mmol/l glucose. The experiments were performed in medium supplemented with 1 mg/ml albumin and containing (in mmol/l): NaCl 125, KCl 5.9, MgCl₂ 1.2, CaCl₂ 1.3, and HEPES 25, titrated to pH 7.4 with NaOH. The flow rate was kept constant throughout each experiment with the aid of a peristaltic pump placed before the islet. Flow variation of 150 to 200 µl/min was allowed between experiments. After 60 to 75 min of introductory perifusion, the perifusate was collected in 20-s fractions directly into microtiter plates.

Insulin measurements.
Insulin was assayed by a competitive enzyme-linked immunosorbent assay (ELISA) with the insulin antibody immobilized directly onto the solid phase. Amounts of insulin down to 100 amol were obtained from linear standard curves in semilogarithmic plots. The insulin-mimetic compound did not interfere with the insulin assay in the concentrations used in the experiments (data not shown).

Data analysis.
Frequency determination of insulin pulses was done by Fourier transformation using the Igor software (Wave Metrics Inc, Lake Oswego, OR). Determination of significant insulin pulses was based on the signal-to-noise ratio as described previously (13).

Statistical analysis.
Results are presented as means ± SE. Differences in rates of secretion and frequencies were evaluated with Students’ two-tailed t test for paired observations.

	RESULTS

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 
Insulin release from individual islets perifused in the presence of 3 mmol/l glucose was 10.5 ± 1.4 pg/min and pulsatile (0.35 ± 0.03 oscillations/min) (Fig. 1). When 10 µmol/l L-783,281 was added to the perifusion medium, there was no change in the rate of secretion, but the pulse frequency decreased significantly (P < 0.02) to 0.22 ± 0.04 oscillations/min. Islets were also perifused in the presence of 11 mmol/l glucose (Fig. 2). Upon introduction of the higher glucose concentration, an initial accentuated peak of insulin was followed by insulin pulses with declining amplitudes (not shown). After 30 min, L-783,281 was added to the perifusion medium containing 11 mmol/l glucose. The addition of the compound increased insulin release from 15.6 ± 4.8 to 64.3 ± 16.9 pg/min. The effect of L-783,281 on the pulse frequency was heterogeneous, and no statistical change could be established.

View larger version (18K): [in this window] [in a new window]   FIG. 1. The effect of L-783,281 on basal insulin release. Single islets of Langerhans were perifused in the presence of 3 mmol/l glucose; 10 µmol/l L-783,281 was added as indicated by the arrow. Representative of seven experiments.

View larger version (21K): [in this window] [in a new window]   FIG. 2. The effect of L-783,281 on glucose-stimulated insulin release. Single islets of Langerhans were perifused in the presence of 11 mmol/l glucose; 10 µmol/l L-783,281 was added as indicated by the arrow. Representatives of five experiments.

	DISCUSSION

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

The mechanisms involved in insulin-induced insulin release have been proposed to involve regulation of the intracellular Ca²⁺ homeostasis via SERCA3 (SERCA, sarco/endoplasmic reticulum calcium ATPase) (15,16). This concept was supported by findings of insulin-induced cytoplasmic Ca²⁺ mobilization from the endoplasmic reticulum (17). The cytoplasmic Ca²⁺ concentration ([Ca²⁺]_c) plays a pivotal role in the regulation of glucose-induced insulin release (18). Oscillations in [Ca²⁺]_c are closely followed by pulses of insulin release (19). The [Ca²⁺]_c oscillations, which appear at stimulatory glucose concentrations, have been found to depend on paracrine factors promoting mobilization of Ca²⁺ from intracellular stores (20). The L-783,281–induced change in pulse frequency was observed at basal glucose, when [Ca²⁺]_c is nonoscillatory. If ß-cell IR activation at basal glucose also induces changes in [Ca²⁺]_c, these changes may be important for the observed alteration in frequency. Insulin resistance in type 2 diabetes may be associated with impaired handling of Ca²⁺ in the endoplasmic reticulum (15,16). Such impaired handling may contribute to the deranged plasma insulin pattern observed in such individuals (21). In healthy subjects, blood insulin levels fluctuate regularly (22).

The importance of the expression of the ß-cell IR was also apparent when the receptor was selectively knocked out in the ß-cell in the so-called ßIRKO mouse, which displays a secretory response to glucose similar to that of type 2 diabetes (23). In contrast to other autocrine feedback systems, the ß-cells seem to signal via positive feedback. This seemingly dangerous self-promoting secretion of the hypoglycemic hormone may be explained by the present observation of glucose dependency of the ß-cell IR–mediated effect.

	ACKNOWLEDGMENTS

 
We wish to express our sincere gratitude to Robert A. Young, University of Pennsylvania, for technical assistance. The study was supported by grants from the Swedish Medical Research Council (72X-14019), the Swedish Diabetes Association, the Novo Nordisk Foundation, the Family Ernfors Foundation, the Marcus and Amalia Wallenberg Foundation, the Swedish Foundation for Strategic Research, the Magnus Bergvalls Foundation, the Göran Gustafsson Foundation, the Swedish Society of Medicine, and National Institutes of Health Grant DK43354.

	FOOTNOTES

 
Address correspondence and reprint requests to johanna.westerlund{at}medcellbiol.uu.se.

Accepted in revised form 22 May 2001.

IR, insulin receptor.

The symposium and the publication of this article have been made possible by an unrestricted educational grant from Servier, Paris

	REFERENCES

TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES

 

1. Ashcroft SJ: Glucoreceptor mechanisms and the control of insulin release and biosynthesis. Diabetologia 18:5–15, 1980[Medline]
2. Patel YC, Amherdt M, Orci L: Quantitative electron microscopic autoradiography of insulin, glucagon, and somatostatin binding sites on islets. Science 217:1155–1156, 1982[Abstract/Free Full Text]
3. Verspohl EJ, Ammon HP: Evidence for presence of insulin receptors in rat islets of Langerhans. J Clin Invest 65:1230–1237, 1980
4. Gazzano H, Halban P, Prentki M, Ballotti R, Brandenburg D, Fehlmann M, Van Obberghen E: Identification of functional insulin receptors on membranes from an insulin-producing cell line (RINm5F). Biochem J 226:867–872, 1985[Medline]
5. Rothenberg PL, Willison LD, Simon J, Wolf BA: Glucose-induced insulin receptor tyrosine phosphorylation in insulin-secreting beta-cells. Diabetes 44:802–809, 1995[Abstract]
6. Harbeck MC, Louie DC, Howland J, Wolf BA, Rothenberg PL: Expression of insulin receptor mRNA and insulin receptor substrate 1 in pancreatic islet beta-cells. Diabetes 45:711–717, 1996[Abstract]
7. Velloso LA, Carneiro EM, Crepaldi SC, Boschero AC, Saad MJ: Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets. FEBS Lett 377:353–357, 1995[Medline]
8. Sun XJ, Pons S, Wang LM, Zhang Y, Yenush L, Burks D, Myers MG, Glasheen E, Copeland NG, Jenkins NA, Pierce JH, White MF: The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol Endocrinol 11:251–262, 1997[Abstract/Free Full Text]
9. Alter CA, Wolf BA: Identification of phosphatidylinositol 3,4,5-trisphosphate in pancreatic islets and insulin-secreting beta-cells. Biochem Biophys Res Commun 208:190–197, 1995[Medline]
10. Gao Z, Konrad RJ, Collins H, Matschinsky FM, Rothenberg PL, Wolf BA: Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase. Diabetes 45:854–862, 1996[Abstract]
11. Aspinwall CA, Lakey JR, Kennedy RT: Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem 274:6360–6365, 1999[Abstract/Free Full Text]
12. Bergsten P, Hellman B: Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets. Diabetes 42:670–674, 1993[Abstract]
13. Bergsten P: Slow and fast oscillations of cytoplasmic Ca²⁺ in pancreatic islets correspond to pulsatile insulin release. Am J Physiol 268:E282–E287, 1995[Abstract/Free Full Text]
14. Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, Royo I, Vilella D, Diez MT, Pelaez F, Ruby C, Kendall RL, Mao X, Griffin P, Calaycay J, Zierath JR, Heck JV, Smith RG, Moller DE: Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284:974–977, 1999[Abstract/Free Full Text]
15. Xu GG, Gao ZY, Borge PD, Jegier PA, Young RA, Wolf BA: Insulin regulation of beta-cell function involves a feedback loop on SERCA gene expression, Ca²⁺ homeostasis, and insulin expression and secretion. Biochemistry 39:14912–14919, 2000[Medline]
16. Xu GG, Gao ZY, Borge PDJ, Wolf BA: Insulin receptor substrate 1-induced inhibition of endoplasmic reticulum Ca²⁺ uptake in beta-cells: autocrine regulation of intracellular Ca²⁺ homeostasis and insulin secretion. J Biol Chem 274:18067–18074, 1999[Abstract/Free Full Text]
17. Aspinwall CA, Qian WJ, Roper MG, Kulkarni RN, Kahn CR, Kennedy RT: Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca²⁺ stores in insulin-stimulated insulin secretion in beta-cells. J Biol Chem 275:22331–22338, 2000[Abstract/Free Full Text]
18. Hellman B, Gylfe E, Bergsten P, Grapengiesser E, Lund PE, Berts A, Dryselius S, Tengholm A, Liu YJ, Eberhardson M, Chow RH: The role of Ca²⁺ in the release of pancreatic islet hormones. Diabete Metab 20:123–131, 1994[Medline]
19. Bergsten P, Grapengiesser E, Gylfe E, Tengholm A, Hellman B: Synchronous oscillations of cytoplasmic Ca²⁺ and insulin release in glucose-stimulated pancreatic islets. J Biol Chem 269:8749–8753, 1994[Abstract/Free Full Text]
20. Liu YJ, Tengholm A, Grapengiesser E, Hellman B, Gylfe E: Origin of slow and fast oscillations of Ca²⁺ in mouse pancreatic islets. J Physiol (Lond) 508:471–481, 1998[Abstract/Free Full Text]
21. Lang DA, Matthews DR, Burnett M, Turner RC: Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30:435–439, 1981[Abstract]
22. Lang DA, Matthews DR, Peto J, Turner RC: Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 301:1023–1027, 1979[Abstract]
23. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329–339, 1999[Medline]

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Srivastava and H. J. Goren Insulin Constitutively Secreted by {beta}-Cells Is Necessary for Glucose-Stimulated Insulin Secretion Diabetes, August 1, 2003; 52(8): 2049 - 2056. [Abstract] [Full Text] [PDF]

				P. D. Borge Jr. and B. A. Wolf Insulin Receptor Substrate 1 Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 3 in Insulin-secreting beta -Cells J. Biol. Chem., March 21, 2003; 278(13): 11359 - 11368. [Abstract] [Full Text] [PDF]

				P. D. Borge, J. Moibi, S. R. Greene, M. Trucco, R. A. Young, Z. Gao, and B. A. Wolf Insulin Receptor Signaling and Sarco/Endoplasmic Reticulum Calcium ATPase in {beta}-Cells Diabetes, December 1, 2002; 51(90003): S427 - 433. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Westerlund, J. Articles by Bergsten, P. Search for Related Content PubMed PubMed Citation Articles by Westerlund, J. Articles by Bergsten, P. Social Bookmarking                What's this?